3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Head & Neck
1
Conditions
Breast Neoplasms
33
Colorectal Neoplasms
13
Neoplasms
11
Pain, Postoperative
10
Lung Neoplasms
9
Brain Neoplasms
8
Stomach Neoplasms
7
Prostatic Neoplasms
7
Pancreatic Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Melanoma
6
Leukemia, Myeloid, Acute
5
Ovarian Neoplasms
4
Myoma
4
Lymphoma, Non-Hodgkin
4
Leiomyoma
4
Hemorrhage
4
Head and Neck Neoplasms
4
Glioblastoma
4
Colonic Neoplasms
4
Agnosia
4
Skin Neoplasms
3
Recurrence
3
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neurotoxicity Syndromes
3
Neoplasm Metastasis
3
Nasopharyngeal Carcinoma
3
Myelodysplastic Syndromes
3
Multiple Endocrine Neoplasia Type 1
3
Interventions
Cisplatin
30
Magnetic Resonance Spectroscopy
21
Radiotherapy
20
pembrolizumab
18
Specimen Handling
17
Cetuximab
16
Radiotherapy, Intensity-Modulated
11
Paclitaxel
11
Carboplatin
11
Fluorouracil
10
Biopsy
10
1,2-diaminocyclohexaneplatinum II citrate
10
Radiation
9
Platinum
9
Drug Therapy
9
Taxes
7
Surgical Procedures, Operative
7
Celecoxib
7
X-Rays
6
Standard of Care
6
Sentinel Lymph Node Biopsy
6
Surveys and Questionnaires
5
Nivolumab
5
cemiplimab
4
Metformin
4
Fluorodeoxyglucose F18
4
Docetaxel
4
Chemoradiotherapy
4
(225)Ac-DOTA-c(RGDyK)
4
durvalumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Mouth Neoplasms
×
Sodium Chloride
×
Clear all
NCT00584597
2010-12-13
TRAUMEEL
University of Oklahoma
Phase 1
Completed
14 enrolled